Member Info for JustHereForHemo

He has explicitly said no placing but some sort of funding related to CDX, so if he is an insider and correct that's a GOOD thing lol 😆. Yes Stu is back, yes he is trying to trade, but he is desperately trying to make a big deal our of a delay at Penn..... which WOULD be a big deal except MD Anderson have leapfrogged Penn and are going to be first.

Anyone who clicks your profile pwil can your intentions. Funny thing is we are actually hoping stu is correct 😆 🤣. There was no big sell off on Friday, but there was more shorts opened, for LTHers that's extremely exciting, we saw a short squeeze in Feb when SP hit 7p, we could see another short squeeze shortly when the RNS Stu predicted lands!

Seriously, don't fall for it, be it anti Israel protest, lack of capacity or facilities, conflict of interest or disagreement over provision of coke vs Pepsi....it does not matter, we care about the FIRST patients, we don't care where (although MD Anderson IS better).

STU JUST WANTS YOU ALL TO FOCUS ON THE DELAY.

He does NOT want people talking about the start of trials at MDA, he does not want us talking about funding arrangements that HE was talking about last week. The Penn delay is mildly interesting, that's it.

This is the post that triggered Stu... Scary when your short.... He is now spending HOURS on here on a weekend, someone is scared 😱

Multiple possibilities:

1, Company X has expressed interest in CDX and CAR-T (They share common antibody, validation of CAR-T is validation of CDX). They have requested Hemo make modifications to improve efficiency of CDX(Done see RNS) and want to see clinical results of CAR-T before licencing. In this scenario they are likely to offer a bridging loan(7-9m) to see the next 6months to a year and allow trials to proceed.

2, Company X have expressed interest in CDX and are offering a bridging loan to allow company to proceed without slowing down progress to IND, the loan being sufficient to cover all expenses for the next year or so and Hemo are free to licence/JV CAR-T independent of Company X.

3, Exclude funds from Company X and Hemo start trials with CAR-T and raise a few mill off the spike that comes, they prove it works with a few patients and MD Anderson unlock funds for the CAR-T trial, at some point the company licence CAR-T

4, No loan, no interest in a placing, no rescue, company goes bust, few people laugh, few people cry, lots of people with AML die.

This list is NOT exhaustive, there are many other possibilities. I believe 1 is most likely, it aligns with statements made by Stu/KP/Vlad/RNSs. It aligns with what we know about Vlad in always going over the big prize at the end instead of small wins. Remember that Penn have funded facilities and MD Anderson are a charity, neither is going to pay the wages at Hemo but both are capable of covering costs of the trials at their facilities so I would not be worried about funding, its not as critical as many make out.

IF I am accurate and 1 is what happens? That means the end of the very destructive peterhouse specials which have tanked the SP here over the years. As for secret groups meeting with Vlad? There is nothing untoward. Vlad used to speak to lots of us, over the years many of us have shared criticism with him and thats all it takes to get blocked, anyone who managed bite their tongue which includes the traders probably still get replies from him :-P But Vlad HAS done interviews and zooms with investors, its not a secret, he has been open and direct, they HAVE been in negotiations with a company over CDX for years now, he has stated funding when CAR-T works will not be an issue and he has always been confident.

Yay, stu is still here 😆🤣😂😹😆🤣😂😹 lasted 30 seconds and he is back

stu, over the years i have had months of poor mental health, some depression, exhaustion etc, some linked to hemo, some health, some kids. why do i tell you this? because from the bottom of my heart i can say my mental health today has never been better, i have never been more optimistic about hemo, and i am absolutely certain that you are short and nervous. enjoy your weekend, however i very greatly doubt you will resist posting. you can't do it. you won't. it's too important, you need to scare people with your irrelevant bs. you need people to sell. me? i just need to wait for news, only a ****** would go short.

You want people to obsess over delays at Penn, making it sound nefarious. IT DOES NOT MATTER. We care about the CAR-T trial, we care about the first patient, we care about results and we care about funding. As much as you WANT people to care about delays at Penn.... we don't! It was a race between them and MD Anderson, MDA won. I don't care if Penn never take part if MDA get the trial underway.

But your desperate for people to care about a delay starting at penn? Why? Why would someone INVESTED dedicate such effort trying to persuade people something irrelevant is uber important? THEY WOULD NOT! Which makes me very happy as the only reason for you going so ape s41t crazy posting today would be if you decided to go short/er yesterday which is hilarious 😂. God I'm going to need to change my pants on Monday if there is an RNS! You have truly made my weekend, what a desperate plonker lol!!

This is the post that triggered Stu... Scary when your short.... He is now spending HOURS on here on a weekend, someone is scared 😱

Multiple possibilities:

1, Company X has expressed interest in CDX and CAR-T (They share common antibody, validation of CAR-T is validation of CDX). They have requested Hemo make modifications to improve efficiency of CDX(Done see RNS) and want to see clinical results of CAR-T before licencing. In this scenario they are likely to offer a bridging loan(7-9m) to see the next 6months to a year and allow trials to proceed.

2, Company X have expressed interest in CDX and are offering a bridging loan to allow company to proceed without slowing down progress to IND, the loan being sufficient to cover all expenses for the next year or so and Hemo are free to licence/JV CAR-T independent of Company X.

3, Exclude funds from Company X and Hemo start trials with CAR-T and raise a few mill off the spike that comes, they prove it works with a few patients and MD Anderson unlock funds for the CAR-T trial, at some point the company licence CAR-T

4, No loan, no interest in a placing, no rescue, company goes bust, few people laugh, few people cry, lots of people with AML die.

This list is NOT exhaustive, there are many other possibilities. I believe 1 is most likely, it aligns with statements made by Stu/KP/Vlad/RNSs. It aligns with what we know about Vlad in always going over the big prize at the end instead of small wins. Remember that Penn have funded facilities and MD Anderson are a charity, neither is going to pay the wages at Hemo but both are capable of covering costs of the trials at their facilities so I would not be worried about funding, its not as critical as many make out.

IF I am accurate and 1 is what happens? That means the end of the very destructive peterhouse specials which have tanked the SP here over the years. As for secret groups meeting with Vlad? There is nothing untoward. Vlad used to speak to lots of us, over the years many of us have shared criticism with him and thats all it takes to get blocked, anyone who managed bite their tongue which includes the traders probably still get replies from him :-P But Vlad HAS done interviews and zooms with investors, its not a secret, he has been open and direct, they HAVE been in negotiations with a company over CDX for years now, he has stated funding when CAR-T works will not be an issue and he has always been confident.

Bottom line.

NOBODY posts here without a reason, Stu can go months posting elsewhere never darkening Hemo, the likes of HT and myself never leave Hemo, Stu is a TRADER. He is not a long term Hemo obsessed genuine holder expressing genuine debate, he is here FOR A REASON. That reason is financial. When he wants the SP to go down he will pick SOMETHING to attack, usually lack of funds but he dug himself a hole this time by admitting a funding RNS is coming so he picked Penn, an irrelevant pointless attack but ANYTHING To cause disruption and FUD.

Either Stu is short or he has sold and wanted to buy back cheaper and the drop yesterday was not big enough or long enough. I Dont care, his days are numbered. I know it, we know it and he knows it. With funding comes volume and it will be impossible to manipulate with impunity as he has done in the past. Roll on the next RNS :-)

This is the post that triggered Stu... Scary when your short....

Multiple possibilities:

1, Company X has expressed interest in CDX and CAR-T (They share common antibody, validation of CAR-T is validation of CDX). They have requested Hemo make modifications to improve efficiency of CDX(Done see RNS) and want to see clinical results of CAR-T before licencing. In this scenario they are likely to offer a bridging loan(7-9m) to see the next 6months to a year and allow trials to proceed.

2, Company X have expressed interest in CDX and are offering a bridging loan to allow company to proceed without slowing down progress to IND, the loan being sufficient to cover all expenses for the next year or so and Hemo are free to licence/JV CAR-T independent of Company X.

3, Exclude funds from Company X and Hemo start trials with CAR-T and raise a few mill off the spike that comes, they prove it works with a few patients and MD Anderson unlock funds for the CAR-T trial, at some point the company licence CAR-T

4, No loan, no interest in a placing, no rescue, company goes bust, few people laugh, few people cry, lots of people with AML die.

This list is NOT exhaustive, there are many other possibilities. I believe 1 is most likely, it aligns with statements made by Stu/KP/Vlad/RNSs. It aligns with what we know about Vlad in always going over the big prize at the end instead of small wins. Remember that Penn have funded facilities and MD Anderson are a charity, neither is going to pay the wages at Hemo but both are capable of covering costs of the trials at their facilities so I would not be worried about funding, its not as critical as many make out.

IF I am accurate and 1 is what happens? That means the end of the very destructive peterhouse specials which have tanked the SP here over the years. As for secret groups meeting with Vlad? There is nothing untoward. Vlad used to speak to lots of us, over the years many of us have shared criticism with him and thats all it takes to get blocked, anyone who managed bite their tongue which includes the traders probably still get replies from him :-P But Vlad HAS done interviews and zooms with investors, its not a secret, he has been open and direct, they HAVE been in negotiations with a company over CDX for years now, he has stated funding when CAR-T works will not be an issue and he has always been confident.

Lots of new lines

Why penn delay?

Dont care

MD Anderson better option anyway

Distraction? No, they approached Hemo LONG before Penn delayed

MAYBE MD Anderson are the cause of the Penn delay? Do I care?

No! I care about start of trials

Do you care?

No! Your just not happy the SP didnt tank yesterday lol!

Sad!

See I can use the enter key aswell.

Multiple possibilities:

1, Company X has expressed interest in CDX and CAR-T (They share common antibody, validation of CAR-T is validation of CDX). They have requested Hemo make modifications to improve efficiency of CDX(Done see RNS) and want to see clinical results of CAR-T before licencing. In this scenario they are likely to offer a bridging loan(7-9m) to see the next 6months to a year and allow trials to proceed.

2, Company X have expressed interest in CDX and are offering a bridging loan to allow company to proceed without slowing down progress to IND, the loan being sufficient to cover all expenses for the next year or so and Hemo are free to licence/JV CAR-T independent of Company X.

3, Exclude funds from Company X and Hemo start trials with CAR-T and raise a few mill off the spike that comes, they prove it works with a few patients and MD Anderson unlock funds for the CAR-T trial, at some point the company licence CAR-T

4, No loan, no interest in a placing, no rescue, company goes bust, few people laugh, few people cry, lots of people with AML die.

This list is NOT exhaustive, there are many other possibilities. I believe 1 is most likely, it aligns with statements made by Stu/KP/Vlad/RNSs. It aligns with what we know about Vlad in always going over the big prize at the end instead of small wins. Remember that Penn have funded facilities and MD Anderson are a charity, neither is going to pay the wages at Hemo but both are capable of covering costs of the trials at their facilities so I would not be worried about funding, its not as critical as many make out.

IF I am accurate and 1 is what happens? That means the end of the very destructive peterhouse specials which have tanked the SP here over the years. As for secret groups meeting with Vlad? There is nothing untoward. Vlad used to speak to lots of us, over the years many of us have shared criticism with him and thats all it takes to get blocked, anyone who managed bite their tongue which includes the traders probably still get replies from him :-P But Vlad HAS done interviews and zooms with investors, its not a secret, he has been open and direct, they HAVE been in negotiations with a company over CDX for years now, he has stated funding when CAR-T works will not be an issue and he has always been confident.

My post immediately prompted a large multi line prepared post from Stu, I wonder why? Guess the drop on friday was not as large as he had hoped for his quick trade, unlucky. Well if he is back I will return to what I did before, I wont engage, let him spend hours writing page after page, and I will copy paste the posts that trigger him. Sorry for the duplication:

Yes/No/Sort of.... There are shareholders who speak to CEO/Directors/brokers, many LTHers do speak outside of LSE, there is or was a Telegram group, IDK if its still going I am not in it. There is/was a twitter group, again not in that as most ended up being traders looking information for personal trading/gain. Bottom line is for a small company like Hemo these groups are too vulnerable to people hijacking to trade via market manipulation so most LTHers dont take part/engage. Alot of us are on Sharediver, less spam than here but still public and nice to keep in touch without the BS and garbage on here.

Multiple possibilities:

1, Company X has expressed interest in CDX and CAR-T (They share common antibody, validation of CAR-T is validation of CDX). They have requested Hemo make modifications to improve efficiency of CDX(Done see RNS) and want to see clinical results of CAR-T before licencing. In this scenario they are likely to offer a bridging loan(7-9m) to see the next 6months to a year and allow trials to proceed.

2, Company X have expressed interest in CDX and are offering a bridging loan to allow company to proceed without slowing down progress to IND, the loan being sufficient to cover all expenses for the next year or so and Hemo are free to licence/JV CAR-T independent of Company X.

3, Exclude funds from Company X and Hemo start trials with CAR-T and raise a few mill off the spike that comes, they prove it works with a few patients and MD Anderson unlock funds for the CAR-T trial, at some point the company licence CAR-T

4, No loan, no interest in a placing, no rescue, company goes bust, few people laugh, few people cry, lots of people with AML die.

This list is NOT exhaustive, there are many other possibilities. I believe 1 is most likely, it aligns with statements made by Stu/KP/Vlad/RNSs. It aligns with what we know about Vlad in always going over the big prize at the end instead of small wins. Remember that Penn have funded facilities and MD Anderson are a charity, neither is going to pay the wages at Hemo but both are capable of covering costs of the trials at their facilities so I would not be worried about funding, its not as critical as many make out.

IF I am accurate and 1 is what happens? That means the end of the very destructive peterhouse specials which have tanked the SP here over the years. As for secret groups meeting with Vlad? There is nothing untoward. Vlad used to speak to lots of us, over the years many of us have shared criticism with him and thats all it takes to get blocked, anyone who managed bite their tongue which includes the traders probably still get replies from him :-P But Vlad HAS done interviews and zooms with investors, its not a secret, he has been open and direct, they HAVE been in negotiations with a company over CDX for years now, he has stated funding when CAR-T works will not be an issue and he has always been confident.

Yes, sadly I did not get a chance to save the deets, but if your looking for a dodgy passport or counterfeit money he was your man!

Either way :-) its blue onwards and upwards!!!

As I have said before, and will repeat, Vlad has made bad decisions HOWEVER how many of those bad decisions was he forced into making? How many placings decimated this company not because Vlad was doing a placing but because the brokers decided to make inside the worst of the worst who took joy and pleasure at destroying the mCap to make a few extra quid. The constant defending of the traders at the expense of always laying blame at Vlads feet is neither fair or accurate. I am certain, absolutly certain that laws have been broken here by traders over the years who have inside traded here. Blame vlad if you want, but save some of that blame for the traders who truly deserve it.

Quote of the day "These balls are hairy, they ain’t crystal."

Hikikomori today @ 10:08

BBB... PURE SPECULATION - Everyone else stop reading.

"who do you think might be their partner?" I wont write name HOWEVER I will give justification:

1, Haywain can give so much more details here than I HOWEVER CAR-T and CDX are tightly bound, if CAR-T works it validates CDX will PROBABLY work. CDX is more expensive to develop HOWEVER has a much much bigger potential target market and therefore value. They have recently released an update which proves progress on CDX AND for the past year+ Vlad has been clear that they are working on CDX with a partner with ongoing discussions. So Point 1 - CDX is VERY MUCH ACTIVE.

2, CAR-T and CDX are in COMPETITION - If CAR-T is a success whoever licences it will have to compete against CDX if it reaches the market, so any funding associated with CAR-T that is subsequently used on CDX would be indirectly funding a future competitor. Does this matter? Do big pharma consider this? Or would the big pharma want to take BOTH CDX and CAR-T off the table together??

3, CDX was not developed alone, there is a company that in-licenced their IP to Hemogenyx but as per the deal have a large vested interest in its success. They will know the technology and potential inside and out and like many pharma are approaching a patent cliff in the coming years. Did they go away? Or were they still in the background working with Hemo supporting the changes made recently to improve efficiency? How with so little money did Hemo make so much progress on CDX whilst also pursuing CAR-T and CBR????

I give even odds its the same company and "They haven't gone away you know". HOWEVER Hemo bought out all IP required to package and sell CDX so it really could be anyone. Either way, someone is lurking in the background and working with Vlad, by the sounds of conversations Kingping has been having we dont have long until we find out who it is.

If Hemogenyx was valued at 200m mCap TODAY and there was no LSE, no trolls, no history of the CLNs and the damage that was done. If Hemogenyx was stood here today with CAR-T about to start trials and in the background CBR and CDX without any of the drama associated with the STOCK AND SHARES... NOBODY would question the mCap. If put in a chart amongst its peers along side oncology pharma in early Phase 1 with CAR-T / cell therapy 200m would be seen as fair, cheap and reasonable.

The current price has NOT been set by experts in this field, it has not been set by brokers or the company or pharma investors and funds. The current SP has been forced and dominated by aggressive trading patterns and behaviours that have suppressed this company for years leading to forced bad decisions including massively undervalued discount placings via brokers who frankly cannot be trusted. The low mCap and SP has forced these mistakes and the low mCap has made it possible for these traders to keep the foot on the neck of this company for so long both in being in-expensive to move the SP and also by taking part in these placings historically and using the information of them to trade.

This current mCap is NOT SUSTAINABLE. The SP is NOT SUSTAINABLE. The traders who have shown expert skill and tradecraft to date cannot and will not stand up to significant volume. They will not win if suddenly Hemogenyx is on the world stage with a massive PR platform having started trials. They will not win if suddenly they dont have cheap shares coming from Peterhouse Capital to close off their short positions.

This (B)U(L)L(S)H(I)T for the past 5 or 6 years is very quickly coming to a close and Hemogenyx W I L L re-rate, and mark my words its coming soon. 50m mCap is a joke for a clinical pharma with a CAR-T which could be licenced TODAY for 100m, so how much of a farce is an mCap of 20m which is what we are right now?......

To those who are short? Good luck and screw you, roll on the re-rate.